First Use of CRISPR Wins Approval

In a follow up to article posted on June 20, 2016, CRISPR Up for Federal Review.

On Tuesday, a federal biosafety and ethics panel approved the first study in patients in an experiment that would use CRISPR to create genetically altered immune cells to attack three kinds of cancer: multiple myeloma, melanoma and sarcoma. Read article here…….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.